Data / Drug companies / Tetracycline-class Drug
Tetracycline-class Drug drugs: 9 drugs from 101 companies in the FDA NDC directory
Tetracycline-class Drug is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 470 products in this class from 101 companies, covering 9 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on September 23, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 101Companies
- 470Products
- 9Drugs by generic name
Drugs in the Tetracycline-class Drug class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Doxycycline | 141 | 63 |
| Doxycycline hyclate | 186 | 61 |
| Minocycline hydrochloride | 127 | 29 |
| Doxycycline monohydrate | 7 | 4 |
| Sarecycline hydrochloride | 3 | 1 |
| Doxyclycline hyclate | 2 | 1 |
| Minocycline | 2 | 1 |
| Doxy 100(tm) doxycycline | 1 | 1 |
| Minocycline hydrochloride extended-release | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 28 | capsule; tablet | Generic drugs (ANDA) | August 1, 2022 |
| A-S Medication Solutions | 21 | capsule; tablet, film coated | Generic drugs (ANDA) | March 7, 2025 |
| Zydus Lifesciences Limited | 20 | tablet, extended release; capsule | Generic drugs (ANDA) | June 12, 2025 |
| Chartwell RX, LLC | 19 | capsule; tablet, film coated | Generic drugs (ANDA) | July 27, 2021 |
| PD-Rx Pharmaceuticals, Inc. | 18 | tablet, film coated, extended release; capsule | Generic drugs (ANDA) | August 21, 2020 |
| Remedyrepack Inc. | 17 | capsule; tablet, film coated | Generic drugs (ANDA) | September 23, 2026 |
| Strides Pharma Science Limited | 16 | tablet; capsule | Generic drugs (ANDA) | May 14, 2026 |
| Zydus Pharmaceuticals USA Inc. | 16 | tablet, extended release; capsule | Generic drugs (ANDA) | June 12, 2025 |
| Alembic Pharmaceuticals Inc. | 14 | capsule; tablet, film coated | Generic drugs (ANDA) | June 27, 2024 |
| Alembic Pharmaceuticals Limited | 14 | capsule; tablet, film coated | Generic drugs (ANDA) | June 27, 2024 |
| Bryant Ranch Prepack | 14 | tablet, film coated, extended release; capsule | Generic drugs (ANDA) | December 23, 2019 |
| NuCare Pharmaceuticals,Inc. | 13 | capsule; tablet, film coated | Generic drugs (ANDA) | August 1, 2022 |
| Aurobindo Pharma Limited | 11 | tablet, film coated, extended release; capsule | Generic drugs (ANDA) | August 21, 2019 |
| Bryant Ranch Prepack | 10 | tablet, film coated, extended release; tablet, film coated | Generic drugs (ANDA) | December 23, 2019 |
| Lupin Pharmaceuticals, Inc. | 9 | tablet, extended release; tablet, coated | Generic drugs (ANDA) | February 22, 2019 |
| Proficient Rx LP | 9 | capsule; tablet | Generic drugs (ANDA) | August 1, 2022 |
| Ascend Laboratories, LLC | 8 | tablet, film coated, extended release | Generic drugs (ANDA) | December 23, 2019 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 8 | tablet, delayed release; tablet | Generic drugs (ANDA) | March 16, 2018 |
| Proficient Rx LP | 8 | capsule; tablet, film coated | Generic drugs (ANDA) | June 28, 2016 |
| Sun Pharmaceutical Industries, Inc. | 7 | tablet, film coated; capsule | Generic drugs (ANDA) | August 6, 2018 |
| Advanced Rx of Tennessee, LLC | 6 | capsule; tablet, film coated | Generic drugs (ANDA) | May 23, 2024 |
| Northwind Health Company, LLC | 6 | capsule; tablet | Generic drugs (ANDA) | February 27, 2023 |
| Redpharm Drug | 6 | tablet; tablet, film coated | Generic drugs (ANDA) | March 7, 2025 |
| Torrent Pharmaceuticals Limited | 6 | tablet; capsule | Generic drugs (ANDA) | April 2, 2015 |
| American Health Packaging | 5 | capsule; tablet, film coated | Generic drugs (ANDA) | April 23, 2026 |
| AvPAK | 5 | capsule; tablet, film coated | Generic drugs (ANDA) | May 15, 2020 |
| Chartwell Governmental & Specialty RX, LLC. | 5 | capsule; tablet, film coated | Generic drugs (ANDA) | July 21, 2021 |
| Direct_Rx | 5 | capsule; tablet, film coated | Generic drugs (ANDA) | January 3, 2025 |
| Proficient Rx LP | 5 | capsule | Generic drugs (ANDA) | March 14, 2016 |
| Actavis Pharma, Inc. | 4 | tablet, delayed release; tablet | Generic drugs (ANDA) | August 14, 2019 |
| Ajanta Pharma USA Inc. | 4 | tablet; capsule | Generic drugs (ANDA) | June 1, 2020 |
| Almirall, LLC | 4 | tablet, coated; capsule | New drug applications (NDA) | January 4, 2019 |
| Asclemed USA, Inc. | 4 | capsule | Generic drugs (ANDA) | January 10, 2022 |
| Hikma Pharmaceuticals USA Inc. | 4 | capsule; tablet, coated | Generic drugs (ANDA) | May 17, 2021 |
| Journey Medical Corporation | 4 | aerosol, foam; tablet | New drug applications (NDA) | March 1, 2025 |
| Lannett Company, Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | August 25, 2008 |
| Lupin Pharmaceuticals,Inc. | 4 | capsule; tablet | Generic drugs (ANDA) | September 6, 2017 |
| Solco Healthcare US, LLC | 4 | tablet, delayed release; capsule | Generic drugs (ANDA) | December 15, 2025 |
| Sun Pharmaceutical Industries, Inc. | 4 | tablet, film coated; capsule | Generic drugs (ANDA) | May 13, 2005 |
| Zydus Pharmaceuticals USA Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | January 11, 2018 |
| Aurobindo Pharma Limited | 3 | tablet, film coated | Generic drugs (ANDA) | May 1, 2020 |
| Coupler LLC | 3 | capsule | Generic drugs (ANDA) | August 18, 2026 |
| Direct RX | 3 | capsule | Generic drugs (ANDA) | April 5, 2019 |
| Fresenius Kabi USA, LLC | 3 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | October 17, 2000 |
| Health Department, Oklahoma State | 3 | capsule; tablet, film coated | Generic drugs (ANDA) | March 7, 2025 |
| Macleods Pharmaceuticals Limited | 3 | capsule; tablet | Generic drugs (ANDA) | December 9, 2025 |
| Major Pharmaceuticals | 3 | capsule; tablet, coated | Generic drugs (ANDA) | April 2, 2015 |
| PD-Rx Pharmaceuticals, Inc. | 3 | capsule | Generic drugs (ANDA) | April 2, 2015 |
| PD-Rx Pharmaceuticals, Inc. | 3 | capsule; tablet, coated | Generic drugs (ANDA) | July 2, 2003 |
| Preferred Pharmaceuticals Inc. | 3 | capsule | Generic drugs (ANDA) | July 30, 2026 |
| Viona Pharmaceuticals Inc | 3 | capsule; tablet | Generic drugs (ANDA) | January 10, 2022 |
| Zydus Lifesciences Limited | 3 | capsule | Generic drugs (ANDA) | March 14, 2016 |
| Cardinal Health 107, LLC | 2 | tablet, coated | Generic drugs (ANDA) | March 22, 2013 |
| Cranbury Pharmaceuticals, LLC | 2 | capsule; tablet | Generic drugs (ANDA) | November 19, 2021 |
| Dr. Reddy's Laboratories Inc. | 2 | capsule; injection, powder, lyophilized, for solution | Generic drugs (ANDA) | July 18, 2025 |
| Epic Pharma, LLC | 2 | tablet; tablet, film coated | Generic drugs (ANDA) | March 7, 2025 |
| Golden State Medical Supply, Inc. | 2 | tablet, film coated; capsule | Generic drugs (ANDA) | December 1, 2000 |
| Lupin Pharmaceuticals, Inc. | 2 | capsule; injection, powder, lyophilized, for solution | Generic drugs (ANDA) | May 31, 2024 |
| Mayne Pharma | 2 | tablet, delayed release; capsule | Authorized generics (NDA) | February 27, 2023 |
| Safecor Health, LLC | 2 | capsule | Generic drugs (ANDA) | September 2, 2026 |
| Slate Run Pharmaceuticals, LLC | 2 | powder, for solution | Generic drugs (ANDA) | July 22, 2024 |
| Sportpharm LLC | 2 | capsule | Generic drugs (ANDA) | January 10, 2022 |
| St. Mary's Medical Park Pharmacy | 2 | tablet; capsule | Generic drugs (ANDA) | August 17, 2023 |
| Zhejiang Yongtai Pharmaceutical Co., Ltd | 2 | capsule | Generic drugs (ANDA) | February 1, 2026 |
| Acella Pharmaceuticals, LLC | 1 | tablet, coated | Generic drugs (ANDA) | August 21, 2020 |
| AiPing Pharmaceutical, Inc. | 1 | capsule | Generic drugs (ANDA) | January 16, 2026 |
| American Health Packaging | 1 | tablet, coated | Generic drugs (ANDA) | March 8, 2013 |
| Amneal Pharmaceuticals LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 6, 2024 |
| Amneal Pharmaceuticals NY LLC | 1 | capsule | Generic drugs (ANDA) | June 28, 2016 |
| Amneal Pharmaceuticals NY LLC | 1 | capsule | Generic drugs (ANDA) | June 28, 2016 |
| Apotex Corp. | 1 | capsule | Generic drugs (ANDA) | October 31, 2024 |
| AvKARE | 1 | capsule | Generic drugs (ANDA) | September 2, 2025 |
| Avenacy, LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | March 1, 2025 |
| Camber Pharmaceuticals, Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | August 5, 2025 |
| Fosun Pharma USA Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 12, 2023 |
| Galderma Laboratories, L.P. | 1 | capsule | New drug applications (NDA) | May 14, 2010 |
| Gland Pharma Limited | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 12, 2023 |
| HF Acquisition Co LLC, DBA HealthFirst | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | October 7, 2019 |
| Hawaii Repack, Inc. | 1 | capsule | Generic drugs (ANDA) | September 11, 1984 |
| Henry Schein, Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | January 10, 2022 |
| Hikma Pharmaceuticals | 1 | capsule | Generic drugs (ANDA) | September 1, 1990 |
| JG Pharma Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | August 1, 2025 |
| Jvet Pharmaceuticals LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | January 27, 2026 |
| Larken Laboratories, Inc. | 1 | tablet | Generic drugs (ANDA) | November 15, 2010 |
| Mayne Pharma Inc. | 1 | tablet, delayed release | New drug applications (NDA) | January 2, 2023 |
| Meitheal Pharmaceuticals Inc. | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | October 28, 2024 |
| Melinta Therapeutics, LLC | 1 | injection | New drug applications (NDA) | April 19, 2013 |
| Mylan Institutional LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | December 20, 2018 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | tablet | Generic drugs (ANDA) | March 14, 2019 |
| Northwind Health Company, LLC | 1 | capsule | Generic drugs (ANDA) | October 4, 2023 |
| Novel Laboratories, Inc. | 1 | tablet | Generic drugs (ANDA) | September 6, 2017 |
| OraPharma, Inc. | 1 | powder | New drug applications (NDA) | March 21, 2011 |
| Par Health USA, LLC | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | November 26, 2024 |
| Piramal Critical Care Inc | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | June 5, 2023 |
| Puracap Laboratories LLC DBA Blu Pharmaceuticals | 1 | tablet, film coated | Generic drugs (ANDA) | March 7, 2025 |
| QPharma, Inc. | 1 | tablet, coated | Generic drugs (ANDA) | July 2, 2003 |
| Quality Care Products LLC | 1 | capsule | Generic drugs (ANDA) | April 16, 2012 |
| Sonoma Pharmaceuticals, Inc. | 1 | tablet, delayed release | Generic drugs (ANDA) | November 28, 2016 |
| Steriscience Specialties Private Limited | 1 | injection, powder, lyophilized, for solution | Generic drugs (ANDA) | May 10, 2026 |
| Unit Dose Solutions, Inc. | 1 | capsule | Generic drugs (ANDA) | June 22, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 213 | 45.3% |
| Tablet, film coated | 68 | 14.5% |
| Tablet | 54 | 11.5% |
| Tablet, film coated, extended release | 44 | 9.4% |
| Injection, powder, lyophilized, for solution | 22 | 4.7% |
| Tablet, delayed release | 20 | 4.3% |
| Tablet, extended release | 20 | 4.3% |
| Tablet, coated | 18 | 3.8% |
| Powder, for suspension | 3 | 0.6% |
| Aerosol, foam | 2 | 0.4% |
| Powder, for solution | 2 | 0.4% |
| Injection | 1 | 0.2% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.